发明名称 ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMUNE COSTIMULATORY AGONIST
摘要 Methods are provided for targeting cells for depletion, including without limitation tumor cells, in a regimen comprising contacting the targeted cells with a combination of agents that modulate immunoregulatory signaling. Immunoregulatory modulating agents include (i) an agent that blockades CD47 activity; and (ii) an agent that agonizes an immune costimulatory molecule, e.g. CD137. The regimen may further comprise an agent that specifically binds to the target cell, e.g. an antibody or biologically active fragment or derivative thereof. The level of depletion of the targeted cell is enhanced relative to a regimen in which a single immunoregulatory modulating agent is used; and the effect may be synergistic relative to a regimen in which a single immunoregulatory modulating agent is used.
申请公布号 WO2017035480(A1) 申请公布日期 2017.03.02
申请号 WO2016US49016 申请日期 2016.08.26
申请人 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 发明人 SCHNORR, Peter;CHHABRA, Akanksha;SHIZURU, Judith A.;WEISSMAN, Irving L.;WEISKOPF, Kipp Andrew
分类号 A61K39/00;A61K39/395;A61P35/00;C07K16/28;C07K16/30 主分类号 A61K39/00
代理机构 代理人
主权项
地址